{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:46:21Z","timestamp":1791229581813,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000006083","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T14:32:53Z","timestamp":1487773973000},"page":"e6083","source":"Crossref","is-referenced-by-count":142,"title":["Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides"],"prefix":"10.1097","volume":"96","author":[{"given":"Roser","family":"Solans-Laqu\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rodriguez-Carballeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Caminal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Mart\u00ednez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Solanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Oristrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pasquau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Callejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Abdilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fanlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"L\u00f3pez-Dupla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Sope\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"P\u00e9rez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep A.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210309","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA-associated vasculitis","volume":"3","author":"Pagnoux","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"R2-9-20210309","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology criteria for the classification of Wegener's Granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R3-9-20210309","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American college of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (Allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R4-9-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R5-9-20210309","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"R6-9-20210309","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R7-9-20210309","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R8-9-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltimore"},{"key":"R9-9-20210309","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Clinical characteristics and long-term follow-up of the 383 Patients enrolled in the French Vasculitis Study Group Cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R10-9-20210309","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/rheumatology\/39.6.585","article-title":"Evidence based-treatment of systemic vasculitis","volume":"39","author":"Jayne","year":"2000","journal-title":"Rheumatology (Oxford"},{"key":"R11-9-20210309","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcome from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R12-9-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R13-9-20210309","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R14-9-20210309","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/rheumatology\/40.7.763","article-title":"Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients","volume":"40","author":"Solans","year":"2001","journal-title":"Rheumatology (Oxford"},{"key":"R15-9-20210309","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0014-2565(00)70017-8","article-title":"Churg-Strauss syndrome. Our two-decade experience","volume":"200","author":"R\u00edos","year":"2000","journal-title":"Rev Clin Esp"},{"key":"R16-9-20210309","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0961203308089693","article-title":"Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis","volume":"17","author":"Solans-Laqu\u00e9","year":"2008","journal-title":"Lupus"},{"key":"R17-9-20210309","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejim.2010.09.005","article-title":"Long-term follow-up of microscopic polyangiitis. 17-year experience at a single center","volume":"21","author":"Borao-Cengotita-Bengoa","year":"2010","journal-title":"Eur J Intern Med"},{"key":"R18-9-20210309","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/ndt\/gfq523","article-title":"A retrospective study on outcome of microscopic polyangiitis in chronic replacement therapy","volume":"26","author":"Merino","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R19-9-20210309","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.otorri.2011.12.002","article-title":"Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)","volume":"63","author":"Morales-Angulo","year":"2012","journal-title":"Acta Otorrinolaringol Esp"},{"key":"R20-9-20210309","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/ctr.12084","article-title":"Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation","volume":"27","author":"Marco","year":"2013","journal-title":"Clin Transplant"},{"key":"R21-9-20210309","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"R22-9-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore"},{"key":"R23-9-20210309","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term follow-up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R24-9-20210309","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R25-9-20210309","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","article-title":"Primary systemic vasculitis: clinical features and mortality","volume":"98","author":"Lane","year":"2005","journal-title":"Q J Med"},{"key":"R26-9-20210309","first-page":"1299","article-title":"Outcome and prognostic factors during the course of primary small-vessel vasculitides","volume":"33","author":"Pavone","year":"2006","journal-title":"J Rheumatol"},{"key":"R27-9-20210309","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/pgmj.2005.034215","article-title":"Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre","volume":"81","author":"Chen","year":"2005","journal-title":"Postgrad Med J"},{"key":"R28-9-20210309","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4238\/2015.May.18.22","article-title":"Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasma antibody-associated vasculitis","volume":"14","author":"Shuai","year":"2015","journal-title":"Genet Mol Res"},{"key":"R29-9-20210309","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis, in a nationwide prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R30-9-20210309","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R31-9-20210309","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R32-9-20210309","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R33-9-20210309","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R34-9-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"R35-9-20210309","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R36-9-20210309","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"De Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"R37-9-20210309","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"R38-9-20210309","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2249.2011.04364.x","article-title":"Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis","volume":"164","author":"Langford","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R39-9-20210309","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","article-title":"Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients","volume":"68","author":"Charlier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R40-9-20210309","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.05610611","article-title":"Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease","volume":"7","author":"McGregor","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-9-20210309","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3899\/jrheum.131426","article-title":"Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients","volume":"41","author":"Lai","year":"2014","journal-title":"J Rheumatol"},{"key":"R42-9-20210309","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/art.27763","article-title":"Improved outcome in 445 patients with Wegener's granulomatosis in a German Vasculitis Center over four decades","volume":"63","author":"Holle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R43-9-20210309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R44-9-20210309","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/rheumatology\/40.5.492","article-title":"Analysis of factors predictive of survival based on 49 patients with systemic Wegener's Granulomatosis and prospective follow-up","volume":"40","author":"Mahr","year":"2001","journal-title":"Rheumatology (Oxford"},{"key":"R45-9-20210309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/41.5.572","article-title":"Predictors of survival and organ damage in Wegener's granulomatosis","volume":"41","author":"Koldingsnes","year":"2002","journal-title":"Rheumatology (Oxford"},{"key":"R46-9-20210309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore"},{"key":"R47-9-20210309","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R48-9-20210309","first-page":"309","article-title":"Wegener's Granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s","volume":"29","author":"Abdou","year":"2002","journal-title":"J Rheumatol"},{"key":"R49-9-20210309","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2008.02060.x","article-title":"Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts","volume":"265","author":"Eriksson","year":"2009","journal-title":"J Intern Med"},{"key":"R50-9-20210309","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/039463200802100317","article-title":"Improvement in relative survival of patients with vasculitis: study of 101 cases compared to the general population","volume":"21","author":"Stratta","year":"2008","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:32Z","timestamp":1620960212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702240-00009"}},"subtitle":["Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006083","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}